Introduction
Methods
Study population
Clinical evaluation
Blood sample analysis
Electrocardiography
Echocardiography
Statistical analysis
Results
Study population and clinical evaluation
Cardiovascular risk factors | |
Hypertension | 12 (24%) |
Hypercholesterolemia | 1 (2%) |
Diabetes mellitus | 1 (2%) |
Obesity (BMI > 30 kg/m2) | 5 (10%) |
Cigarette smoking | |
Present | 5 (10%) |
Previous | 15 (29%) |
Previous cardiac history | |
Myocardial infarction | 8 (16%) |
Coronary revascularisation | 3 (6%) |
Conduction abnormalities | 5 (10%) |
Requiring pacemaker | 2 (4%) |
Pericarditis | 1 (2%) |
Heart failure | 1 (2%) |
Mitral valve abnormalities | 2 (4%) |
Requiring valve replacement | 1 (2%) |
Cardiovascular medications | |
β-blockers | 10 (20%) |
Calcium-antagonists | 4 (8%) |
ACE-inhibitors | 7 (14%) |
Diuretics | 8 (16%) |